SH3GLB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.116200E-01
Normal-vs-Stage2
7.823200E-01
Normal-vs-Stage3
5.739000E-01
Normal-vs-Stage4
2.461200E-01
Stage1-vs-Stage2
4.972600E-01
Stage1-vs-Stage3
6.812800E-01
Stage1-vs-Stage4
1.116220E-01
Stage2-vs-Stage3
3.294000E-01
Stage2-vs-Stage4
1.595420E-01
Stage3-vs-Stage4
1.181980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.770000E-01
Normal-vs-AfricanAmerican
5.902800E-01
Normal-vs-Asian
9.217000E-01
Caucasian-vs-AfricanAmerican
4.696800E-01
Caucasian-vs-Asian
6.228600E-01
AfricanAmerican-vs-Asian
4.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.987000E-01
Normal-vs-Female
7.661000E-01
Male-vs-Female
6.008800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.595400E-01
Normal-vs-Age(41-60Yrs)
3.569000E-01
Normal-vs-Age(61-80Yrs)
9.755200E-01
Normal-vs-Age(81-100Yrs)
5.398400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.170790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.902200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.908800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.779000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.756000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.739000E-01
Normal-vs-Daily Drinker
9.021200E-01
Normal-vs-Weekly Drinker
8.672000E-01
Normal-vs-Occasional Drinker
5.370000E-01
Normal-vs-Social Drinker
8.079800E-01
Non Drinker-vs-Daily Drinker
2.983800E-01
Non Drinker-vs-Weekly Drinker
6.953200E-01
Non Drinker-vs-Occasional Drinker
3.275900E-02
Non Drinker-vs-Social Drinker
2.124200E-01
Daily Drinker-vs-Weekly Drinker
6.260200E-01
Daily Drinker-vs-Occasional Drinker
3.844000E-01
Daily Drinker-vs-Social Drinker
8.658200E-01
Weekly Drinker-vs-Occasional Drinker
1.776190E-01
Weekly Drinker-vs-Social Drinker
5.014000E-01
Occasional Drinker-vs-Social Drinker
4.935200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.448000E-01
Normal-vs-Grade 2
4.009800E-02
Normal-vs-Grade 3
1.040980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.641900E-04
Grade 1-vs-Grade 3
3.444100E-02
Grade 1-vs-Grade 4
4.448000E-01
Grade 2-vs-Grade 3
1.913180E-01
Grade 2-vs-Grade 4
4.009800E-02
Grade 3-vs-Grade 4
1.040980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.433600E-01
Normal-vs-NonDiabetic
8.794400E-01
Diabetic-vs-NonDiabetic
4.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.423200E-01
Normal-vs-NoPancreatitis
9.412200E-01
Pancreatitis-vs-NoPancreatitis
2.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.988200E-01
Normal-vs-N1
7.455000E-01
N0-vs-N1
2.739000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.073600E-01
Normal-vs-TP53-NonMutant
6.321200E-01
TP53-Mutant-vs-TP53-NonMutant
4.639300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
